Figure 1: The 3+PRN and 1+PRN treatment protocols. Patients on the 3+PRN regimen received two additional consecutive monthly intravitreal ranibizumab injections independent of clinical findings compared with patients treated according to the 1+PRN protocol. The need for additional injections was determined by the same retreatment criteria as patients assigned to the 1+PRN schedule from baseline.